bf/NASDAQ:ALZN_icon.jpeg

NASDAQ:ALZN

Alzamend Neuro, Inc.

  • Stock

USD

Last Close

0.62

16/05 20:00

Market Cap

5.77M

Beta: -

Volume Today

94.11K

Avg: 184.60K

PE Ratio

−0.38

PFCF: −0.69

Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
net income
-4.86M
-
-4.41M
9.30%
-5.05M
14.43%
-12.36M
144.96%
-14.88M
20.35%
depreciation and amortization
3.55K
-
23.07K
549.93%
deferred income tax
-1.71M
-
stock based compensation
396.17K
-
1.80M
354.73%
2.03M
12.81%
4.41M
116.92%
3.58M
18.73%
change in working capital
1.23M
-
-299.35K
124.34%
-152.45K
49.07%
1.33M
970.56%
2.35M
77.02%
accounts receivables
inventory
accounts payables
693.58K
-
1.71M
146.15%
other working capital
1.23M
-
-299.35K
124.34%
-152.45K
49.07%
633.60K
515.61%
-1.71M
369.46%
other non cash items
2.19M
-
562.28K
74.34%
454.63K
19.14%
8.77K
98.07%
1.71M
19,367.18%
net cash provided by operating activities
-1.05M
-
-2.35M
124.43%
-2.71M
15.61%
-6.61M
143.88%
-8.92M
34.91%
investments in property plant and equipment
-106.46K
-
acquisitions net
purchases of investments
5.37M
-
sales maturities of investments
other investing activites
234.09K
-
105K
55.14%
100.92K
3.89%
-5.37M
5,425.78%
net cash used for investing activites
234.09K
-
105K
55.14%
100.92K
3.89%
-106.46K
205.49%
debt repayment
-16.80K
-
-1.92K
88.58%
-58.67K
2,958.76%
common stock issued
236.02K
-
2.29M
869.54%
2.10M
8.23%
18.91M
800.55%
989.33K
94.77%
common stock repurchased
dividends paid
other financing activites
72.70K
-
16.93K
76.71%
2.35M
13,789.31%
2.20K
99.91%
-989.13K
45,060.64%
net cash used provided by financing activities
308.72K
-
2.29M
641.28%
4.45M
94.46%
18.85M
323.70%
200
100.00%
effect of forex changes on cash
net change in cash
-502.39K
-
47.68K
109.49%
1.84M
3,757.01%
12.13M
559.85%
-8.92M
173.53%
cash at beginning of period
545.00K
-
42.61K
92.18%
90.28K
111.91%
1.93M
2,036.87%
14.06M
628.97%
cash at end of period
42.61K
-
90.28K
111.91%
1.93M
2,036.87%
14.06M
628.97%
5.14M
63.45%
operating cash flow
-1.05M
-
-2.35M
124.43%
-2.71M
15.61%
-6.61M
143.88%
-8.92M
34.91%
capital expenditure
-106.46K
-
free cash flow
-1.05M
-
-2.35M
124.43%
-2.71M
15.61%
-6.72M
147.80%
-8.92M
32.78%

All numbers in USD (except ratios and percentages)